Implantable cardioverter-defibrillators (ICDs) are used in selected patients with
Hypertrophic cardiomyopathy (HCM), who are considered at high risk for sudden cardiac
death
1
,2
. The unique anatomical features of this population raise concerns regarding the feasibility
of successful defibrillation. Therefore, despite scarce evidence and advances in the
design of contemporary ICDs, dual coil leads are still endorsed by some for HCM patients.
Yet, this choice is associated with increased complication rate during lead extraction.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart RhythmAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References:
- 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.Eur Heart J. Oct 21 2022; 43: 3997-4126
- 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. Dec 22 2020; 142: e558-e631
- Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy.Am J Cardiol. Jun 15 2020; 125: 1896-1900
Article info
Publication history
Accepted:
March 14,
2023
Received in revised form:
March 13,
2023
Received:
November 16,
2022
Publication stage
In Press Journal Pre-ProofFootnotes
Davidai Arrhythmia Center, Leviev Heart Center Sheba medical center, Tel Hashomer, Israel, 5265601.
Sackler School of Medicine, Tel Aviv University
The authors have no conflict of interests to declare.
Identification
Copyright
© 2023 Published by Elsevier Inc. on behalf of Heart Rhythm Society.
